Balyasny Asset Management’s DMK Pharmaceuticals DMK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
– Sell
-23,179
Closed -$1.78M – 2541
2021
Q2
$1.78M Buy
+23,179
New +$1.41M 0.01% 1059
2018
Q1
– Sell
-3,157
Closed -$972K – 2405
2017
Q4
$972K Buy
3,157
+300
+11% +$98.7K ﹤0.01% 1344
2017
Q3
$1.04M Buy
+2,857
New +$1.01M ﹤0.01% 1152

Other funds holding DMK

Balyasny Asset Management's DMK Position: Q3 2021 in Review

Balyasny Asset Management sold out of DMK Pharmaceuticals (DMK) in Q3 2021, closing a stake of 23,179 shares — an estimated $1.78M sold.

Balyasny Asset Management first reported a position in DMK in Q3 2017 and held it in 3 quarters. The position peaked at $1.78M in Q2 2021. 52 funds tracked by Wall St. Rank hold DMK as of Q3 2021.

  • Balyasny Asset Management reported no remaining DMK Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • Balyasny Asset Management sold 23,179 DMK Pharmaceuticals shares in Q3 2021, an estimated $1.78M.
  • Balyasny Asset Management first reported a position in DMK Pharmaceuticals in Q3 2017 and held it in 3 quarters.
  • Balyasny Asset Management's DMK Pharmaceuticals position peaked at $1.78M in Q2 2021.
  • 52 funds tracked by Wall St. Rank held DMK Pharmaceuticals as of Q3 2021.

Based on Balyasny Asset Management's 13F filing for Q3 2021, filed 15 Nov 2021.